Preliminary research conducted by Children’s Hospital, Boston indicates that the Alzheimer’s drug, Namenda, may help to protect premature infants from developing cerebral palsy. The study has been published in the Journal of Neuroscience.
During testing with rats, researchers discovered that the rats that were treated with Namenda suffered less brain damage after loss of blood and oxygen to the brain.
Often, premature infants suffer from severe brain damage due to birth trauma. The birth trauma results in a loss of blood and oxygen to the brain, which can cause serious life-long disabilities, such as cerebral palsy.
Additional testing of Namenda needs to be completed.
Birth injuries that result in cerebral palsy can be caused by negligence on the part of the medical staff. Birth trauma attorneys
are working on seeking out negligent doctors and facilities to prevent birth injury from occurring.
